文献速递头颈外科

早期口咽癌 upfront 手术与根治性放疗的比较:竞争风险分析

Upfront Surgery Versus Definitive Radiotherapy: Competing Risk Analyses in Early Stage Oropharyngeal Cancer.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-01-30

基于监测、流行病学和最终结果数据库的1877例T1-2N0-1M0口咽癌患者,回顾性比较upfront手术与根治性放疗的生存结局。在HPV阴性队列中,根治性放疗与癌症特异性死亡(校正SHR 2.29,95%CI 1.42-3.68,p=.001)和非癌死亡(校正SHR 2.74,95%CI 1.50-5.02,p=.001)风险升高独立相关;在HPV阳性队列中,两种治疗方式的癌症特异性和非癌生存结局相似。

要点

  • HPV阴性早期口咽癌中,根治性放疗与癌症特异性死亡风险升高独立相关(校正SHR 2.29)。
  • HPV阴性早期口咽癌中,根治性放疗与非癌死亡风险升高独立相关(校正SHR 2.74)。
  • HPV阳性早期口咽癌中,upfront手术与根治性放疗的癌症特异性和非癌生存结局相似。

核心结论

  • 在HPV阴性早期口咽癌患者中,upfront手术与较低的癌症特异性和非癌死亡率相关。
  • 在预后较好的HPV阳性早期口咽癌中,两种治疗方式的癌症特异性和非癌生存结局疗效相似。
  • 作者认为未来需要精心设计的前瞻性临床试验来证实这些发现。

研究设计与样本

  • 回顾性观察性研究,数据来自公开可用的监测、流行病学和最终结果数据库。
  • 共纳入1877例T1-2N0-1M0口咽癌患者。
  • 主要终点为癌症特异性死亡和非癌死亡,采用累积发生率函数估计并用Gray检验比较。
  • 采用单因素和多因素Fine-Gray亚分布风险模型估计治疗方式对死亡率的影响。
  • 在倾向评分匹配队列中进行亚组分析,所有分析分别在HPV阴性和HPV阳性队列中单独进行。

主要发现

  • 在HPV阴性队列中,根治性放疗与癌症特异性死亡风险升高独立相关(校正SHR 2.29,95%CI 1.42-3.68,p=.001)。
  • 在HPV阴性队列中,根治性放疗与非癌死亡风险升高独立相关(校正SHR 2.74,95%CI 1.50-5.02,p=.001)。
  • 在HPV阳性队列中,根治性放疗与upfront手术可达到相似的癌症特异性和非癌生存结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the survival outcomes of early-stage oropharyngeal cancer (OPC) patients treated with upfront surgery versus definitive radiotherapy (RT). STUDY DESIGN: Retrospective observational study. SETTING: Publicly available database. METHODS: A total of 1877 patients with T1-2N0-1M0 OPC were retrieved from the Surveillance, Epidemiology, and End Results database. Primary endpoints were cancer-specific and noncancer mortalities, which were estimated using cumulative incidence function and compared by Gray's test. Univariate and multivariate Fine-Gray subdistribution hazard models were used to estimate the effects of treatment modality on mortality. Subgroup analyses were performed in propensity-score-matched cohorts. All the analyses were conducted separately in human papillomavirus (HPV)-negative and HPV-positive cohorts. RESULTS: In the HPV-negative cohort, definitive RT was independently associated with increased risk of cancer-specific mortality (adjusted subdistribution hazard ratio [SHR], 2.29; 95% confidence interval [CI], 1.42-3.68; p = .001) and noncancer mortality (adjusted SHR, 2.74; 95% CI, 1.50-5.02; p = .001). In the HPV-positive cohort, definitive RT and upfront surgery could achieve similar cancer-specific and noncancer survival outcomes. CONCLUSION: Upfront surgery is associated with lower cancer-specific and noncancer mortality in HPV-negative early-stage OPC patients. However, in the setting of HPV-positive early-stage OPC with better prognosis, the 2 treatment modalities have similar efficacy in terms of cancer-specific and noncancer survival outcomes. In the future, carefully designed prospective clinical trials are needed to confirm our findings.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Peng L, Zeng XL, Fang RH, et al. Upfront Surgery Versus Definitive Radiotherapy: Competing Risk Analyses in Early Stage Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2023. PMID: 36939469. doi:10.1002/ohn.245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。